Normal mammary fibroblasts induce reversion of the malignant phenotype in human primary breast cancer.
By: Anna-Maria Römer, Inke Lühr, Andreas Klein, Andreas Friedl, Susanne Sebens, Frank Rösel, Norbert Arnold, Alexander Strauss, Walter Jonat, Maret Bauer

Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Arnold-Heller-Str. 3, 24105 Kiel, Germany. maret_bauer@yahoo.de.
2013-4-9; doi:
Abstract

Unlabelled

Background/Aim: The tumor microenvironment plays a major role in tumor growth and progression. Its manipulation can lead to a reversion of the malignant phenotype. Here we explored the ability of normal mammary fibroblasts (HMFs) to induce reversion of the malignant phenotype of primary breast carcinoma cells (PBCs) in a three-dimensional (3D) context.

Materials

PBCs were isolated from 13 primary breast carcinomas and cultured in 3D collagen-I gels as mono- or co-culture with HMFs.

Results

In five co-cultures, PBCs exhibited reversion of their malignant phenotype, whereas PBCs in matched monocultures exhibited disorganized growth. Reversion, defined as the restoration of the complete baso-apical polarity axis, was confirmed with established polarity markers. Secretion of the tissue-specific glycoprotein MAM-6 into the acinar lumens and deposition of basement membrane indicated functional differentiation. Gene expression analysis revealed a set of differentially regulated genes which possibly affect the reversion process. These included MAL, ELF5, MAP6, ZMYND11 and SQLE.

Conclusion

These findings highlight the significant role of fibroblasts in regulating the carcinoma phenotype.





PMID:23564794






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements